Developing Therapeutic Antibodies to Maximize Efficacy
Alder's ALD403 is a novel monoclonal antibody targeting calcitonin gene-related peptide (CGRP) in Phase 3 trials for the prevention of migraine headaches.
Changing the Definition of Sequencing
With the GemCode Platform, 10x Genomics researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows.
Revolutionizing Type 2 Diabetes and Obesity
Intarcia's device is a matchstick-sized osmotic pump that delivers GLP-1 (Glucagon-Like Peptide-1) in a manner that avoids the need for regular, painful injections while producing efficacy and tolerability results.
Reversing Tumors Associated With Immunosuppression
Arcus is pursuing small-molecule and protein-based therapeutics to block active immunosuppression pathways and selectively stimulate the tumor-killing activity of effector immune cells.
Protecting People From Food Allergens
Aimmune’s characterized oral desensitization immunotherapy (CODIT™) system combines proprietary product candidates with gradual, controlled up-dosing protocols to obtain meaningful desensitization to food allergens.
Addressing Glaucoma With Triple-Action Eyedrops
Aerie is developing first-in-class once-daily eye drops with the ability to reduce intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension.